4.80
price up icon2.56%   0.12
after-market アフターアワーズ: 4.80
loading
前日終値:
$4.68
開ける:
$4.75
24時間の取引高:
24,448
Relative Volume:
1.43
時価総額:
$43.42M
収益:
$23.84M
当期純損益:
$-3.81M
株価収益率:
-9.60
EPS:
-0.5
ネットキャッシュフロー:
$-713.00K
1週間 パフォーマンス:
+1.27%
1か月 パフォーマンス:
-21.05%
6か月 パフォーマンス:
-26.38%
1年 パフォーマンス:
+29.73%
1日の値動き範囲:
Value
$4.72
$5.36
1週間の範囲:
Value
$4.52
$5.36
52週間の値動き範囲:
Value
$3.55
$7.60

Immucell Corp Stock (ICCC) Company Profile

Name
名前
Immucell Corp
Name
セクター
Healthcare (1136)
Name
電話
(207) 878-2770
Name
住所
56 EVERGREEN DR, PORTLAND, ME
Name
職員
77
Name
Twitter
Name
次回の収益日
2024-11-13
Name
最新のSEC提出書
Name
ICCC's Discussions on Twitter

ICCC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ICCC
Immucell Corp
4.80 42.33M 23.84M -3.81M -713.00K -0.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.17 109.05B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
784.61 82.75B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.12 56.78B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.63 56.52B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.51 44.58B 447.02M -1.18B -906.14M -6.1812

Immucell Corp (ICCC) 最新ニュース

pulisher
Nov 24, 2025

ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada

Nov 24, 2025
pulisher
Nov 21, 2025

Will ImmuCell Corporation stock sustain high P E ratiosM&A Rumor & Safe Investment Capital Preservation Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength - Yahoo Finance

Nov 20, 2025
pulisher
Nov 20, 2025

Why ImmuCell Corporation stock is a must watch in 2025Trade Risk Report & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will ImmuCell Corporation bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to monitor ImmuCell Corporation with trend dashboards2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 15, 2025

ImmuCell Corporation (NASDAQ:ICCC) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 15, 2025
pulisher
Nov 14, 2025

ImmuCell Corp. Experiences Valuation Adjustment Amidst Strong Yearly Performance Metrics - Markets Mojo

Nov 14, 2025
pulisher
Nov 14, 2025

What catalysts could drive ImmuCell Corporation stock higherWeekly Risk Report & Community Consensus Trade Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Earnings call transcript: ImmuCell Q3 2025 sees stock dip amid revenue fall - Investing.com Canada

Nov 14, 2025
pulisher
Nov 14, 2025

ImmuCell Q3 2025 slides: Improved margins despite revenue dip, Re-Tain awaits FDA - Investing.com

Nov 14, 2025
pulisher
Nov 14, 2025

How ImmuCell Corporation (IUL) stock valuation compares with sectorJuly 2025 Trends & Long-Term Growth Stock Strategies - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 13, 2025

ImmuCell Corporation Reports Third Quarter 2025 Financial Results with Significant Year-Over-Year Improvements in Net Income and Gross Margin - Quiver Quantitative

Nov 13, 2025
pulisher
Nov 13, 2025

[8-K] IMMUCELL CORP /DE/ Reports Material Event | ICCC SEC FilingForm 8-K - Stock Titan

Nov 13, 2025
pulisher
Nov 13, 2025

ImmuCell (NASDAQ: ICCC) posts $1.8M net income for nine months; gross margin at 42.6% - Stock Titan

Nov 13, 2025
pulisher
Nov 12, 2025

Financial Review: CompuMed (OTCMKTS:CMPD) vs. ImmuCell (NASDAQ:ICCC) - Defense World

Nov 12, 2025
pulisher
Nov 11, 2025

Multi asset correlation models including ImmuCell CorporationJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com

Nov 11, 2025
pulisher
Nov 06, 2025

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 - The Manila Times

Nov 06, 2025
pulisher
Nov 06, 2025

ImmuCell (NASDAQ: ICCC) schedules third-quarter results for Nov 13; call Nov 14 - Stock Titan

Nov 06, 2025
pulisher
Nov 05, 2025

Why ImmuCell Corporation stock is seen as undervaluedWeekly Earnings Recap & Verified Short-Term Plans - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

What MACD signals say about ImmuCell CorporationJuly 2025 Selloffs & Verified Entry Point Detection - newser.com

Nov 05, 2025
pulisher
Nov 04, 2025

ImmuCell appoints Olivier te Boekhorst as new CEO - Investing.com

Nov 04, 2025
pulisher
Nov 04, 2025

ImmuCell appoints Olivier te Boekhorst as new CEO By Investing.com - Investing.com Canada

Nov 04, 2025
pulisher
Nov 04, 2025

ImmuCell Corporation Announces Appointment of New CEO Olivier te Boekhorst and Board Changes - Quiver Quantitative

Nov 04, 2025
pulisher
Nov 04, 2025

ImmuCell (NASDAQ: ICCC) names Olivier te Boekhorst CEO, effective Nov 1, 2025 - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat

Nov 04, 2025
pulisher
Nov 03, 2025

Will ImmuCell Corporation stock rally after Fed decisionsProfit Target & Fast Gain Swing Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is ImmuCell Corporation stock positioned for long term growthSwing Trade & Reliable Intraday Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Will ImmuCell Corporation stock gain from lower inflationJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 02, 2025

Immucell Corp (ICCC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.84
price up icon 0.76%
$31.92
price up icon 1.66%
$105.65
price up icon 0.09%
$102.70
price up icon 3.00%
biotechnology ONC
$340.64
price up icon 1.63%
$204.51
price down icon 2.16%
大文字化:     |  ボリューム (24 時間):